Navigation Links
Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
Date:6/9/2009

Cardiatis SA, today announced that its Multilayer Aneurysm Repair System (MARS) has received CE Mark approval for treating patients with peripheral aneurysms. Product rollout is underway.

Brussels, Belgium (PRWEB) June 9, 2009 -- Cardiatis, SA announced today that it has received CE Mark approval for the commercial sale of its Multilayer Aneurysm Repair System.

The Multilayer Aneurysm Repair System (MARS) is based on non-invasive paradigm shifting technology that treats aneurysms, regardless of their location, endovasculary through hemodynamic flow modulation and parent artery repair techniques. The received CE Mark is for the peripheral indication and clinical development is underway for cerebral and thoraco-abdominal aortic aneurysm indications.

Due to novelty of the technology, Cardiatis has initiated limited rollout of the product to select interventional centers where physician training is underway.

"We are very pleased to provide physicians and patients with Cardiatis breakthrough Multilayer Aneurysm Repair System", said Noureddine Frid, Cardiatis president and chief executive officer. "Physicians will now have access to a new minimally-invasive technology that will allow them to treat peripheral aneurysms endovasculary while preserving precious collateral circulation."

The Multilayer Aneurysm Repair System (MARS) has proven to be highly deliverable and is effective in excluding aneurysms from circulation while preserving collaterals. It also offers an excellent safety profile, which is important to both physicians and patients.

More than 95% of peripheral artery aneurysms occur in males, and the average age of patients at presentation is 65 years. Atherosclerosis appears to be the etiology in more than 90% of cases. Popliteal artery aneurysms are the most common peripheral artery aneurysms accounting for up to 85% of total aneurysms in the periphery.

About Cardiatis

Cardiatis, an innovative medical technology company located in Belgium, is focused on developing and commercializing its patented Multilayer technology platform, a next generation technology for endovascular aneurysm repair. Additional information can be found on Cardiatis web site at www.cardiatis.com.

###

Read the full story at http://www.prweb.com/releases/Endovascular/Aneurysm/prweb2507714.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Too Few Screened for Abdominal Aneurysm, Study Says
2. NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
3. Less Invasive Interventional Treatment Can Be Recommended as First-Line Treatment for Silent Killer, Abdominal Aortic Aneurysm
4. Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms
5. Aneurysms in 2nd Generation May Not Come Early
6. Routine testing after aneurysm coiling carries low risk
7. Brain Aneurysm Rupture Risk Tied to Location, Size
8. The Brain Aneurysm Foundation Announces 2008 Research Grant Recipients
9. NYC first: Complex aneurysm treated using new fenestrated endograft stent
10. Carnegie Mellon researchers improve assessments of aortic aneurysms
11. Women, Mexican-Americans at higher risk of ruptured brain aneurysm
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
(Date:1/17/2017)... , ... January 17, 2017 , ... ... supplement, Healthful-Flex. , The company, owned and operated by Ed Stroup, was ... a reasonable price with the highest level of customer service. Healthful Balance products ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... the National Association of Music Merchants (NAMM) winter trade show, Booth #2876, at ... Etymotic’s ER•4® has long been the gold standard for high-definition, in-ear earphones. This ...
(Date:1/17/2017)... ... 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting provider ... in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted that ... , Produced by Zeltiq, CoolSculpting is approved by the Food and Drug Administration ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... lecture to primary eye care practitioners on the latest breakthroughs in the prevention, ... Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ...
(Date:1/17/2017)... ... 17, 2017 , ... Neil H. Greco Insurance Agency, a northern New Jersey ... region, is launching a charity drive to raise awareness of heart disease and promote ... in America, and is responsible for 1 in every 4 deaths at the national ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- Precision medicine is an emerging approach to ... The approach allows doctors and physicians to study ... studies the individual profile at a genetic level ... 2015, Precision Medicine Initiative (PMI) was announced to ... than one million volunteers. All of The Unified ...
(Date:1/17/2017)... 17, 2017 EU5 Glucose Monitoring Market Outlook ... "EU5 Glucose Monitoring Market Outlook to 2022", provides key ... report provides value, in millions of US dollars, volume ... - Blood Glucose Meters, Blood Glucose Test Strips and ... distribution shares data for each of these market segements, ...
(Date:1/17/2017)... Jan. 17, 2017 The Global Nebulizers Market ... 8.2% over the next decade to reach approximately $1698.68 ... the market is witnessing include rapidly growing demand in ... advancements in nebulizer products and online marketing strategies by ... market is categorized into pneumatic nebulizers, ultrasonic nebulizers and ...
Breaking Medicine Technology: